KBLB · Kraig Biocraft Laboratories, Inc.
$0.08
+0.00 (+0.25%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As reflected in the accompanying financial statements, the Company has a working capital deficiency of $7,326,899 and stockholders' deficiency of $6,751,116 and used $1,128,413 of cash in operations for the six months ended June 30, 2026. This raises substantial doubt about its ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company's ability to raise additional capital and implement its business plan. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$89.23M
Shares
1.12B
Volume · Oct 20
1.26M
Avg daily vol (3M)
957.57K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.08
Open$0.08
Day$0.08–0.09
52W close$0.07–0.16
Avg vol 30d1.3M
Short int200K · 0.0% float · 1.0d
Short vol46%
DataJan 2020–Oct 2026
Filing10-Q · Aug 13
Up next
filed Aug 13, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$0
Trailing 12 months
Net income (TTM)
−$4.15M
Trailing 12 months
Revenue growth YoY
+312.7%
Year over year
Operating margin
-239.0%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+6.0%
Year over year · more shares
Price change (1Y)
-9.7%
Trailing year
Short interest
0.0%
Latest settlement · 1.0 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Weak
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 17.3 · elevated
Equity put/call 0.56
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−23%
below
Price vs 50-day avg
−4%
below
RSI (14)
44
neutral
MACD trend
Negative
52-week position
13%
near low
Momentum
relative strength
1-month return
+13%
trailing
6-month return
−46%
trailing
YTD return
−10%
this year
Relative strength
−54%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Accumulating
+100% holders QoQ · +1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.02% of float · ▲ +3822.4% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
2 holders — mid 4-yr range
Squeeze score
37
low risk · 0–100
Fundamentals
Revenue growth
+313%
Y/Y
Free cash flow
$-1.8M
Balance sheet
$45.0K
net cash
Quant / Vol
risk profile
Volatility
95%
annualized · 1-yr
Max drawdown
−57%
past year
ATR
11.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−23%
Bearish
Price vs 50-day avg
−4%
Neutral
RSI (14)
44
Neutral
MACD trend
Negative
Bearish
52-week position
13%
Bearish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Accumulating
+100% holders QoQ · +1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.02% of float · ▲ +3822.4% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
2 holders — mid 4-yr range
Price context
position in its 52-week range
Range low $0
Now $0 · 13%
Range high $0
vs 200-day avg -23%
vs 50-day avg -4%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
Versus peers
Specialty Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
KBLB
this stock
Kraig Biocraft Laboratories, Inc.
|
$89.23M | -9.7% | +312.7% | — | 0.0% |
|
LIN
Linde PLC
|
$231.36B | +17.4% | +3.0% | 32.4 | 1.3% |
|
AIQUF
L Air Liquide SA
|
$124.04B | +3.5% | — | — | 0.0% |
|
SHW
Sherwin Williams Co
|
$81.57B | +4.1% | +2.1% | 31.0 | 2.8% |
|
ECL
Ecolab Inc.
|
$80.78B | +9.7% | +2.2% | 38.7 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Accumulating
Holders
2
- % held
- 0.0%
- Net QoQ
- +13.0K sh
- Top holder
- Hurley Capital, LLC
Held
Float
Short & Settlement
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| KBLB | -7.4% | +13.1% | -45.8% | -26.6% | -9.7% |
| SPY | -1.2% | -0.6% | +8.1% | +0.8% | +12.8% |
| vs SPY | -6.3% | +13.6% | -53.9% | -27.5% | -22.5% |